XORTX to focus on late stage allopurinol intolerant gout program; discussion with FDA planned for first half 2025 regarding ...

The refractory gout market is growing because of the rising prevalence of gout brought on by aging populations and changes in ...

XORTX Therapeutics (XRTX) announces the launch of a new late stage program to treat gout. The new drug development program – XRx-026 – will ...

Colchicine in combination with probenecid or allopurinol is frequently used to treat gouty flares ... for managing chronic gout is the use of uric-acid-lowering drugs to reduce urate production ...

Colchicine, a cheap and readily available anti-inflammatory drug used to treat diseases such as gout, is to be investigated as a potential therapy for COVID-19 in the UK’s ground-breaking ...

For patients with gout who cannot get relief ... Now, phase 3 results with a new drug from Sobi and Selecta suggests there could be another treatment option in the offing. Armed with a pair ...

Some other medicines that are slated to become blockbusters in the near future include GSK’s vaccine candidate GSK-3536819 ...

Diseases of the joints are known as arthritis. The term is derived from the Greek word that means exactly that: diseases of ...

A recent study highlights a surprising issue for people living with gout in the United States: most gout flares are never ...

Treatment for gout typically involves a combination of medications to manage pain and inflammation during acute attacks and prevent future flare-ups, as well as lifestyle modifications to reduce ...